Skip Nav Destination
Issues
Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
Radhika A. Patel; Ilsa Coleman; Martine P. Roudier; Eric Q. Konnick; Brian Hanratty; Ruth Dumpit; Jared M. Lucas; Lisa S. Ang; Jin-Yih Low; Maria S. Tretiakova; Gavin Ha; John K. Lee; Lawrence D. True; Angelo M. De Marzo; Peter S. Nelson; Colm Morrissey; Colin C. Pritchard; Michael C. Haffner
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer
Margaret L. Axelrod; Yu Wang; Yaomin Xu; Xiaopeng Sun; Cosmin A. Bejan; Paula I. Gonzalez-Ericsson; Sara Nunnery; Riley E. Bergman; Joshua Donaldson; Angel L. Guerrero-Zotano; Chiara Massa; Barbara Seliger; Melinda Sanders; Ingrid A. Mayer; Justin M. Balko
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
Stefano Marastoni; Ainhoa Madariaga; Aleksandra Pesic; Sree Narayanan Nair; Zhu Juan Li; Zvi Shalev; Troy Ketela; Ilaria Colombo; Victoria Mandilaras; Michael Cabanero; Jeff P. Bruce; Xuan Li; Swati Garg; Lisa Wang; Eric X. Chen; Sarbjot Gill; Neesha C. Dhani; Wenjiang Zhang; Melania Pintilie; Valerie Bowering; Marianne Koritzinsky; Robert Rottapel; Bradly G. Wouters; Amit M. Oza; Anthony M. Joshua; Stephanie Lheureux
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
Paul A. Hamlin; Vasile Musteata; Steven I. Park; Christine Burnett; Kristina Dabovic; Thomas Strack; Eric T. Williams; Banmeet S. Anand; Jack P. Higgins; Daniel O. Persky
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
Anne W.J. Martens; Joanne M. Rietveld; Renate de Boer; Fleur S. Peters; An Ngo; Lotte W.H.G. van Mil; Koen de Heer; Marcel Spaargaren; Christie P.M. Verkleij; Niels W.C.J. van de Donk; Homer C. Adams, III; Eric Eldering; Carel J.M. van Noesel; Raluca Verona; Arnon P. Kater
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
Husain Yar Khan; Misako Nagasaka; Yiwei Li; Amro Aboukameel; Md. Hafiz Uddin; Rachel Sexton; Sahar Bannoura; Yousef Mzannar; Mohammed Najeeb Al-Hallak; Steve Kim; Rafic Beydoun; Yosef Landesman; Hirva Mamdani; Dipesh Uprety; Philip A. Philip; Ramzi M. Mohammad; Anthony F. Shields; Asfar S. Azmi
Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia
Glenn J. Hanna; Alessandro Villa; Nikhil Mistry; Yonghui Jia; Charles T. Quinn; Madison M. Turner; Kristen D. Felt; Kathleen Pfaff; Robert I. Haddad; Ravindra Uppaluri; Scott J. Rodig; Sook-Bin Woo; Ann Marie Egloff; F. Stephen Hodi
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds